Home > Latest > Contents

Hainan-based JV hailed as key green project at China-Japan environmental forum

Updated: February 15, 2023 Source: Belt and Road Portal
fontLarger fontSmaller

Bloomage Biotech.png

Visitors view exhibits at the booth of Bloomage Biotech at the second China International Consumer Products Expo (CICPE) in Haikou, south China's Hainan Province, July 26, 2022. A batch of domestic brands have attracted a lot of visitors at the expo. (Xinhua/Yang Guanyu)

The joint venture (JV) set up by Chinese major hyaluronic acid producer Bloomage Biotech, Japanese firms ROHTO Pharmaceutical Co., Ltd. (ROHTO) and BioMimetics Sympathies (BMS) was recognized as a key green project at the 16th China-Japan Comprehensive Forum on Energy Saving and Environmental Protection, according to Bloomage Biotech on Monday.

The joint venture, founded in July 2022, has been settled in the Haikou National High-tech Zone of south China's Hainan Province. The launch of the joint venture represents a strategic step of  Bloomage Biotech to chart the territory of regenerative medicine and cell culture medium industry.

The forum is co-organized by China's National Development and Reform Commission (NDRC), Ministry of Commerce (MOC), Japan's Ministry of Economy, Trade and Industry, and the Japan-China Economic Association.

Editor: Yang Yifan